We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

142 hedge funds and large institutions have $584M invested in Cytokinetics in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 41

16.24% more ownership

Funds ownership: 76.89% → 93.13% (+16%)

14% more capital invested

Capital invested by funds: $513M → $584M (+$70.5M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 25

4% less funds holding

Funds holding: 148 → 142 (-6)

13% less call options, than puts

Call options by funds: $2.59M | Put options by funds: $2.98M

Holders
142
Holders Change
-6
Holders Change %
-4.05%
% of All Funds
2.8%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
25
Increased
51
Reduced
41
Closed
25
Calls
$2.59M
Puts
$2.98M
Net Calls
-$389K
Net Calls Change
-$3.94M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$31.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$26.7M
3
Morgan Stanley
Morgan Stanley
New York
+$11.2M
4
Jennison Associates
Jennison Associates
New York
+$6.27M
5
Millennium Management
Millennium Management
New York
+$5.94M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$8.57M
2
OM
Opaleye Management
Massachusetts
-$7.4M
3
SI
Sofinnova Investments
California
-$2.4M
4
PVI
Pura Vida Investments
New York
-$2.14M
5
N
Nuveen
North Carolina
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$3.41M +$38.1K +3,714 +1%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.89M +$2.38M +232,113 +574%
SFM
28
Sphera Funds Management
Israel
$2.85M +$2.76M +268,747 New
SDIC
29
South Dakota Investment Council
South Dakota
$2.85M -$377K -36,710 -12%
N
30
Nuveen
North Carolina
$2.61M -$1.79M -174,381 -41%
Hudson Bay Capital Management
31
Hudson Bay Capital Management
Connecticut
$2.39M +$2.31M +225,000 New
Deutsche Bank
32
Deutsche Bank
Germany
$2.06M +$171K +16,694 +9%
EP
33
Eversept Partners
New York
$1.93M – – –
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$1.88M +$115K +11,225 +7%
GPP
35
Great Point Partners
Connecticut
$1.7M +$1.64M +160,073 New
Renaissance Technologies
36
Renaissance Technologies
New York
$1.63M +$857K +83,467 +119%
CAM
37
ClariVest Asset Management
California
$1.62M -$286K -27,846 -15%
Legal & General Group
38
Legal & General Group
United Kingdom
$1.57M +$119K +11,597 +8%
Susquehanna International Group
39
Susquehanna International Group
Pennsylvania
$1.43M -$277K -26,982 -17%
Public Sector Pension Investment Board (PSP Investments)
40
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.4M -$155K -15,100 -10%
PAI
41
Palo Alto Investors
California
$1.31M – – –
Wells Fargo
42
Wells Fargo
California
$1.31M +$194K +18,879 +18%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.3M +$339K +33,025 +37%
CEP
44
Chicago Equity Partners
Illinois
$1.26M -$288K -28,020 -19%
JP Morgan Chase
45
JP Morgan Chase
New York
$1.13M +$905K +88,102 +483%
MCP
46
Mirador Capital Partners
California
$1.09M +$1.05M +102,476 New
PPA
47
Parametric Portfolio Associates
Washington
$1.07M -$158K -15,420 -13%
Federated Hermes
48
Federated Hermes
Pennsylvania
$1.03M -$8.57M -834,163 -90%
Swiss National Bank
49
Swiss National Bank
Switzerland
$1.01M +$33.9K +3,300 +4%
Prudential Financial
50
Prudential Financial
New Jersey
$971K +$2.57K +250 +0.3%
1
2
3 4 5

CYTK Hedge Fund Activity: Q4 2019 in Review

142 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2019, worth a combined $584M — up 14% from $513M a quarter earlier.

Fund positioning in CYTK was balanced in Q4 2019: 25 funds opened new positions, 25 closed out, 51 added to existing stakes and 41 trimmed.

The largest buyer was BVF Inc, adding an estimated $31.2M. The largest seller was Federated Hermes, cutting an estimated $8.57M.

  • 142 institutional investors held Cytokinetics (CYTK) as of Q4 2019, down from 148 in Q3 2019.
  • Funds reported $584M of Cytokinetics stock for Q4 2019, up 14% quarter-over-quarter.
  • 25 funds opened new Cytokinetics positions in Q4 2019 and 25 closed out, a net change of 0 holders.
  • The largest Cytokinetics buyer in Q4 2019 was BVF Inc, an estimated $31.2M added.
  • The largest Cytokinetics seller in Q4 2019 was Federated Hermes, an estimated $8.57M sold.

Based on aggregated 13F filings for Q4 2019.